Merck (MRK) stock gains as new oral HIV tablet matches Gilead's (GILD) three-drug once-daily HIV pill Biktarvy in a Phase 3 ...
Aug. 19, 2025 A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation signature, researchers developed an mRNA-based treatment that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback